Skip to Main Content

Paper Details

Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
Lancet HIV,The
19
2021
CD4, Doravirine, HIV, HIV-1, HIV-1 RNA, HIV-1 infection, Islatravir, Participants, TDF, creatinine, doravirine, islatravir, lamivudine, nucleoside, nucleoside reverse transcriptase, participant, participants, plasma, tenofovir disoproxil fumarate, to doravirine

Datasets

Release 1.2